ABSTRACT Five experimental petroleum extracts were produced from luboil distillates derived from Middle East paraffinic crude by solvent extraction and severe hydrotreatment. The polycyclic aromatic content (PCA) of the extracts was determined by dimethyl sulphoxide extraction and ranged from 3-7-9-2% w/w. The five extracts were evaluated for their potential to induce cutaneous and systemic neoplasia in female mice derived from Carworth Farm No 1 strain (CF1). The test substances were applied undiluted (0-2 ml per application) to the shorn dorsal skin twice weekly for up to 78 weeks, with 48 mice in each treatment group and 96 in the untreated control group; two further groups, each of 48 mice, were similarly treated either with a non-hydrotreated commercial aromatic extract (PCA content, 19*7% w/v) or with a low dose of benzo(a)pyrene (12-5 ,ug/ml acetone). The mice were housed individually in polypropylene cages in specified pathogen free conditions. The incidence of cutaneous and systemic tumours was determined from histological analysis of haematoxylin and eosin stained tissue sections. The results were correlated with the PCA content of the extracts and compared with those from female mice exposed to a non-hydrotreated commercial aromatic extract. Four of the hydrotreated extracts were carcinogenic for murine skin; the two products with the lower PCA contents were less carcinogenic than the products with the higher PCA contents and all were less carcinogenic than the commercial extract. One extract with the lowest PCA content was noncarcinogenic. Thus refining by severe hydrotreatment was an effective method of reducing the carcinogenic potential of petroleum aromatic extracts. Although other physicochemical properties may influence the biological activity of oil products, the PCA content determined by dimethyl sulphoxide extraction may be a useful indicator of the potential of oil products to induce cutaneous tumours in experimental animals. There was no evidence that the commercial or hydrotreated extracts increased the incidence of systemic neoplasms when applied twice weekly to the dorsal skin.
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In 1932 several pure polycyclic aromatic compounds (PCA) were shown to induce malignant tumours in laboratory animals after topical application to the interscapular skin or after subcutaneous injection. ' The authors suggested, on the basis of fluorescent properties, that PCA compounds were the carcinogens in such complex mixtures as coal tars, shale oil, and heated petroleum products. With the isolation of 3,4-benzo(a)pyrene from coal tar,2 the presence of an identified chemical carcinogen could be associated with the carcinogenic property of an industrial product. There is now substantial evidence3 that the potential of some oils and oil products to induce tumours in laboratory animals is due, at least in part, to their content of PCA compounds.
Aromatic extracts are the byproduct of solvent extraction in the refining of petroleum oils. These extracts have a high PCA content (more than 5% by weight) and will contain some carcinogenic 4-6 membered condensed ring structures. A research programme was designed to investigate whether aromatic extracts could be developed with acceptable functional properties and low carcinogenic activity. A at necropsy and from the paired inguinal, brachial, and axillary lymph nodes of animals with cutaneous nodules. Cutaneous tumours were diagnosed by histological criteria and designated benign or malignant. Some epidermal tumours sloughed spontaneously; although no histological diagnosis of these tumours was possible, they were classified as benign for the purposes of statistical analysis, provided that they had attained a diameter of 2 mm and had persisted thereafter for at least two weeks.
Assessment of cutaneous irritation was made from the degree of epidermal acanthosis induced by treatment. The epidermal thickness was expressed as the mean number of of nucleated cell layers counted at 10 sites along a sagittal section of skin from the treated site. The mean was designated the irritancy value. The irritancy values so derived were grouped according to treatment and survival. Four periods were evaluated, weeks 1-20, 21-40, 41-60, and 61-78 . The number of animals in each period varied, since only those animals dying or killed during each period were evaluated. No animals were specifically detailed for necropsy before the end of the 78 week study to determine irritative effects of treatment.
STATISTICAL ANALYSES
Percentage survival at the end of the study for each of the treatment groups was tested against the untreated control group using Fisher's exact 2 x 2 test.
The number of mice with cutaneous tumours (>2 mm) of the treated site and with systemic tumours were analysed separately, using the methods described by Peto eta!6 which allow for intercurrent mortality. For cutaneous tumours, the time from initial treatment to the development of the first tumour of 2 mm diameter was noted; using this information the observed and expected numbers of mice with such tumours were determined for each of the seven treated groups. The expected numbers of mice with systemic tumours were calculated taking into account whether each tumour was fatal or incidental. Each tumour was regarded as either fatal, if it was directly or indirectly the cause of death, or incidental.
The hypothesis that the groups had been exposed to a homogeneous risk of tumour development was tested using the X2 statistic, which is based on the difference between the observed (0) and the expected (E) numbers of mice with tumours.
Significantly large values of X2 imply rejection of this hypothesis, and the ratios of the observed to expected (O:E) indicate the variation in this risk among the groups. For both cutaneous and systemic tumours, analysis was concerned with the seven treated groups and the control group, with increased risk in the treated groups compared with control being of interest; X2 is distributed as approximately chi-square on seven degrees of freedom.
The probability of avoiding a 2 mm cutaneous tumour through the duration of the study for the groups was depicted as a life Primary cutaneous irritation was induced at the treated site after exposure to all the aromatic extracts except HTAE 5; 50% of mice treated with HTAE 3 and HTAE 4 and nearly all mice exposed to CAE, HTAE 1, and HTAE 2 were affected.
Secondary ulcerative lesions were seen on the neck and shoulders of many treated animals; sometimes the ulceration extended to the forelimbs and flanks. These lesions were self inflicted by scratching in response to irritation induced by treatment of the dorsal skin. Secondary lesions of this type, arising from minor abrasions incurred during normal grooming, were also seen in three untreated controls, three mice exposed to B-a-P, and five to HTAE 5.
The number of nucleated epidermal cell layers was assessed histologically from sections of the dorsal skin of all animals with intact interfollicular epidermis. Table 7 lists the incidence of major lesions. With the exception of HTAE 5, the incidence and severity of acute inflammatory lesions in the liver, stomach, and kidneys were increased in the treated groups compared with those in both the control groups; these lesions included hepatic microabscesses, focal coagulative hepatic parenchymal necrosis, focal and diffuse gastritis, and suppurative nephritis. Hepatic (HTAE 1-4) .
Chronic non-suppurative nephritis was identified in 15% of the mice. This lesion was often associated with systemic hypertensive and degenerative vascular lesions, particularly arteritis of the ovarian and superior mesenteric vessels. Neither the incidence nor the severity of these lesions was increased by exposure to the aromatic extracts. Similarly, the incidence of hepatic single cell necrosis, focal hepatic parenchymal hyperplasia, and hydronephrosis was unaffected by treatment when compared with that in the untreated controls. Expected No tumour bearing mice (E)
18-9 7-6 2-1 3-2 2-6 7-4 7 5 9-6 4-1 O:E ratio Test statistic distributed approx as chi square on 7 degrees of freedom (chi-square distribution 5% point is 14-1). Absence of a figure denotes no finding.
had PCA contents of 9-2%, 8-7%, and 6-0% w/w respectively. The experimental extract, HTAE 3, had been hydrotreated in a refinery plant and was not dewaxed; the PCA content (6.1% w/w) was similar to that of the solvent dewaxed HTAE 4. The experimental extract HTAE 5, with the lowest PCA content (3-7% w/w), was a solvent dewaxed hydrotreated residual oil from pilot plant production. These five products were tested for their potential to induce cutaneous and systemic neoplasia in female CF1 mice by application to the shorn dorsal skin for up to 78 weeks. The results were compared with those following application of a non-hydrotreated commercial aromatic extract (CAE) with a PCA content of 19-7% w/w. The major factors responsible for reduced survival were cutaneous ulceration or cutaneous neoplasia, or both, both lesions being related to treatment. The relative importance of the two lesions differed among the groups; cutaneous ulceration was the more important cause of premature morbidity in mice exposed to the four hydrotreated extracts HTAE 1-4, whereas cutaneous neoplasia was of greater significance in mice exposed to CAE.
Cutaneous neoplasia and ulceration adversely affected the health and survival of animals. Many of the neoplasms were large, ulcerated, and haemorrhagic; in a small number of mice, pulmonary metastases of cutaneous tumours were associated with clinical signs of respiratory distress. Cutaneous ulceration of the treated site or adjacent skin, often aggravated by scratching, was often associated with cachexia. Infection of and blood loss from areas of ulceration were major factors responsible for loss of weight and debility of affected mice. Multifocal acute inflammatory lesions in liver and kidneys were frequently associated with extensive cutaneous ulceration; septicaemia and toxaemia resulting from infection of the ulcers were major secondary factors contributing to premature mortality.
In control, HTAE 5, and B-a-P treated animals systemic neoplasia and inflammatory lesions, particularly chronic nephritis, were of relatively greater importance as causes of illness and mortality. These diseases represent natural causes of death of CF1 female mice in this laboratory and are primarily diseases of older animals. The higher percentage incidence in control, HTAE 5, and B-a-P decedents reflected the longer survival of animals in these groups compared with that in the other test groups.
The cutaneous carcinogenic potential of the extracts was assessed by both clinical observations and histological examination. A definitive clinical diagnosis of a cutaneous tumour was made when a nodule of 2 mm diameter persisted for two weeks. Use of these clinical criteria facilitated differentiation between small neoplastic lesions and focal inflammatory or hyperplastic lesions. Furthermore, since some cutaneous papillomas slough spontaneously, clinical data on the development of these tumours represented the only permanent record of their existence. The positive control compound (B-a-P, 12-5 ,ug/ml acetone) induced cutaneous tumours in 13% of treated animals, showing the susceptibility of female CF1 mice to a low dose of a known polycyclic aromatic carcinogen.
Five of the six aromatic extracts were cutaneous carcinogens for CF1 female mice. The commercial extract (CAE) had the highest carcinogenic potential, inducing the greatest number of tumours and with the shortest latent period; cutaneous tumours were induced in almost all animals of this group. This extract had a similar PCA content to that of the feedstock from which three of the hydrotreated products, HTAE 1, HTAE 2, and HTAE 4, were processed. After severe hydrotreatment, the carcinogenic potential of the extracts was reduced; HTAE 1 and HTAE 2, with PCA contents of 9-2 and 8-7% w/w respectively, were four times less likely to induce cutaneous tumours than CAE. The extracts HTAE 3 and HTAE 4, with lower PCA contents (6-1 and 6*0% w/w), were relatively weak carcinogens and HTAE 5 with the lowest PCA content (3.7% w/w) was non-carcinogenic for murine skin. These results show that decreasing PCA content, as measured by dimethyl sulphoxide extraction, correlates with decreased cutaneous carcinogenic potential.
There was no evidence that exposure to the commercial or experimental hydrotreated extracts Doak, Hend, van der Wiel, and Hunt induced tumours at sites other than the treated dorsal skin.
The results of this study show that severe hydrotreatment reduces the carcinogenic potential of aromatic extracts of petroleum. Physicochemical properties other than PCA content-for example, viscosity or the presence of cocarcinogens3 are likely to influence the biological activity of complex products. Nevertheless, the PCA content of a product, determined by dimethyl sulphoxide extraction, may be a useful indicator of carcinogenic potential.
